What is the share price of Mono Pharmacare Ltd (MONOPHARMA) today?
The share price of MONOPHARMA as on 7th July 2025 is ₹25.45. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Mono Pharmacare Ltd (MONOPHARMA) share?
The past returns of Mono Pharmacare Ltd (MONOPHARMA) share are- Past 1 week: N/A%
- Past 1 month: 1.38%
- Past 3 months: 8.07%
- Past 6 months: -25.15%
- Past 1 year: -35.57%
- Past 3 years: N/A%
- Past 5 years: -16.42%
What are the peers or stocks similar to Mono Pharmacare Ltd (MONOPHARMA)?
The peers or stocks similar to Mono Pharmacare Ltd (MONOPHARMA) include:What is the market cap of Mono Pharmacare Ltd (MONOPHARMA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Mono Pharmacare Ltd (MONOPHARMA) is ₹44.97 Cr as of 7th July 2025.What is the 52 week high and low of Mono Pharmacare Ltd (MONOPHARMA) share?
The 52-week high of Mono Pharmacare Ltd (MONOPHARMA) is ₹41.95 and the 52-week low is ₹22.10.What is the PE and PB ratio of Mono Pharmacare Ltd (MONOPHARMA) stock?
The P/E (price-to-earnings) ratio of Mono Pharmacare Ltd (MONOPHARMA) is 14.65. The P/B (price-to-book) ratio is 1.60.Which sector does Mono Pharmacare Ltd (MONOPHARMA) belong to?
Mono Pharmacare Ltd (MONOPHARMA) belongs to the Consumer Discretionary sector & Retail - Speciality sub-sector.How to buy Mono Pharmacare Ltd (MONOPHARMA) shares?
You can directly buy Mono Pharmacare Ltd (MONOPHARMA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Mono Pharmacare Ltd
MONOPHARMA Share Price
MONOPHARMA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MONOPHARMA Performance & Key Metrics
MONOPHARMA Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 1.60 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
38.59 | 6.32 | 0.65% |
MONOPHARMA Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
MONOPHARMA Company Profile
Mono Pharmacare is a distributor and supplier of pharmaceutical products and medicines, providing an extensive array of healthcare products, antibiotics, and more.
MONOPHARMA Forecast
MONOPHARMA Forecasts
MONOPHARMA
MONOPHARMA
Income
Balance Sheet
Cash Flow
MONOPHARMA Income Statement
MONOPHARMA Income Statement
Financial Year | FY 2023 | FY 2024 | FY 2025 | TTM | ||||
---|---|---|---|---|---|---|---|---|
Total Revenue | 27.22 | 122.44 | 169.32 | — | ||||
Raw Materials | 34.19 | 120.28 | 160.71 | — | ||||
Power & Fuel Cost | 0.01 | 0.04 | ||||||
Employee Cost | 0.54 | 2.62 | ||||||
Selling & Administrative Expenses | 0.84 | 2.14 | ||||||
Operating & Other expenses | -10.11 | -9.15 | ||||||
EBITDA | 1.75 | 6.51 | 8.61 | — | ||||
Depreciation/Amortization | 0.05 | 0.12 | 0.13 | — | ||||
PBIT | 1.70 | 6.39 | 8.48 | — | ||||
Interest & Other Items | 0.77 | 3.15 | 4.03 | — | ||||
PBT | 0.93 | 3.24 | 4.45 | — | ||||
Taxes & Other Items | 0.23 | 0.79 | 1.38 | — | ||||
Net Income | 0.70 | 2.45 | 3.07 | — | ||||
EPS | 0.57 | 1.63 | 1.75 | — | ||||
DPS | 0.00 | 0.00 | 0.00 | — | ||||
Payout ratio | 0.00 | 0.00 | 0.00 | — |
MONOPHARMA Company Updates
MONOPHARMA Stock Peers
MONOPHARMA Past Performance & Peer Comparison
MONOPHARMA Past Performance & Peer Comparison
Consumer DiscretionaryRetail - Speciality
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Mono Pharmacare Ltd | 14.65 | 1.60 | — |
Aditya Vision Ltd | 43.74 | 7.91 | 0.31% |
Landmark Cars Ltd | 134.81 | 3.96 | 0.10% |
Baazar Style Retail Ltd | 146.30 | 9.98 | — |
MONOPHARMA Stock Price Comparison
Compare MONOPHARMA with any stock or ETFMONOPHARMA Holdings
MONOPHARMA Shareholdings
MONOPHARMA Promoter Holdings Trend
MONOPHARMA Promoter Holdings Trend
MONOPHARMA Institutional Holdings Trend
MONOPHARMA Institutional Holdings Trend
No institutional holdings trend are available
MONOPHARMA Shareholding Pattern
MONOPHARMA Shareholding Pattern
MONOPHARMA Shareholding History
MONOPHARMA Shareholding History
smallcases containing MONOPHARMA stock
smallcases containing MONOPHARMA stock
Looks like this stock is not in any smallcase yet.
MONOPHARMA Events
MONOPHARMA Events
MONOPHARMA Dividend Trend
MONOPHARMA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
MONOPHARMA Dividend Trend
MONOPHARMA has not given any dividends in last 5 years
MONOPHARMA Dividends
MONOPHARMA Dividends
MONOPHARMA Stock News & Opinions
MONOPHARMA Stock News & Opinions
Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 11 April 2025.Powered by Capital Market - Live
Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 2 April 2025.Powered by Capital Market - Live
Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 10 February 2025.Powered by Capital Market - Live
Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 11 January 2025.Powered by Capital Market - Live
Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Mono Pharmacare announced that the 2nd Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 6 September 2024.Powered by Capital Market - Live
Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 6 August 2024.Powered by Capital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant